explore
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers
Next article: ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers
explore
focus
-
IRA could hurt research into orphan drugs for rare diseases
2025-09-30 20:33 -
ASCO: AstraZeneca's hat trick, and palliative care's spotlight
2025-09-30 20:06 -
Hospitals consider fixing cancer drug shortages on their own
2025-09-30 19:11 -
How medical schools plan to diversify without affirmative action
2025-09-30 18:31 -
BMI, flaws aside, is found to be useful estimate of body fat in youth
2025-09-30 18:28 -
ASCO: Palliative care found as helpful given virtually as in person
2025-09-30 18:08